Patent Assignment
Reel/Frame 056268/0983
Assignment of Assignor's Interest
Recorded: 2021-05-18
Pages: 10
Assignor
DYAX CORP.
Executed: 2021-02-26
Assignee
TAKEDA PHARMACEUTICAL COMPANY LIMITED
1-1, DOSHOMACHI 4-CHOME,, CHUO-KU, OSAKA-SHI,, OSAKA, JAPAN
Covered Properties
(102)
Novel Methods of Constructing Libraries Comprising Displayed and/or Expressed Members of a Diverse Family of Peptides, Polypeptides or Proteins and the Novel Libraries
Kunitz Domain Peptides
Ligand Screening and Discovery
Methods for Preserving Organs and Tissues
Prevention and Reduction of Blood Loss
Display library process
TIE1-Binding Ligands
Kallikrein-Inhibitor Therapies
Metalloproteinase-Binding Proteins
Antibodies to TIE1 Ectodomain
Kallikrein Inhibitors and Anti-Thrombolytic Agents and Uses Thereof
Antibodies That Bind Hk-1
Method of Inhibition of Vascular Development Using an Antibody
Prevention and Reduction of Blood Loss
Binding Molecules for Human Factor Viii and Factor Viii-Like Proteins
Novel methods of constructing libraries of genetic packages that collectively display the members of a diverse family of peptides, polypeptides or proteins
Poly-Pegylated Protease Inhibitors
Kallikrein-Inhibitor Therapies
Methods for Preserving Organs and Tissues
Protease Inhibition
Antibodies That Bind Mmp-14
Ligand Screening and Discovery
Kallikrein Inhibitors and Anti-Thrombolytic Agents and Uses Thereof
Prevention and Reduction of Blood Loss
Kallikrein-Inhibitor Therapies
Prevention and Reduction of Blood Loss
Prevention and Reduction of Blood Loss
HK1-Binding Proteins
Compositions and Methods for Treating Osteolytic Disorders Comprising Mmp-14 Binding Proteins
Metalloproteinase 9 Binding Proteins
Metalloproteinase-12 Specific Monoclonal Antibody
Metalloproteinase 9 and Metalloproteinase 2 Binding Proteins
Kdr and Vegf/Kdr Binding Peptides and Their Use in Diagnosis and Therapy
Multi-Chain Eukaryotic Display Vectors and Uses Thereof
Treatment of Mucositis with Kallikrein Inhibitors
Methods and Compositions for Purifying Human Factor Viii, Factor Viii-Like Proteins or Fragments Thereof
Methods for Preserving Organs and Tissues
Metalloproteinase Binding Proteins
Compositions and Methods for Treating Ophthalmic Disorders
Libraries of Genetic Packages Comprising Novel Hc CDR3 Designs
Prevention and Reduction of Blood Loss
Plasma Kallikrein Binding Proteins
Libraries of Genetic Packages Comprising Novel Hc CDR1, CDR2, and CDR3 and Novel Lc CDR1, CDR2, and CDR3 Designs
Multi-Chain Eukaryotic Display Vectors and Uses Thereof
Focused Libraries of Genetic Packages
Focused Libraries of Genetic Packages
Multi-Chain Eukaryotic Display Vectors and Uses Thereof
Multi-Chain Eukaryotic Display Vectors and Uses Thereof
Multi-Chain Eukaryotic Display Vectors and Uses Thereof
Metalloproteinase 9 Binding Proteins
Kallikrein-Inhibitor Therapies
Binding Molecules for Human Factor Viii and Factor Viii-Like Proteins
Focused Libraries of Genetic Packages
Method for Treating Breast Cancer Using Antibody Binding to Mmp-14
Compositions and Methods for Treating Osteolytic Disorders Comprising Mmp-14 Binding Proteins
Plasma Kallikrein Binding Proteins
Kallikrein Inhibitors and Anti-Thrombolytic Agents and Uses Thereof
Ligand Screening and Discovery
Multi-Chain Eukaryotic Display Vectors and Uses Thereof
Binding Molecules for Human Factor Viii and Factor Viii-Like Proteins
Kdr and Vegf/Kdr Binding Peptides and Their Use in Diagnosis and Therapy
Display Library Process
Novel Fab Fragment Libraries and Methods for Their Use
Human Neonatal Fc Receptor Antibodies and Methods of Use Thereof
Prevention and Reduction of Blood Loss
Kallikrein Inhibitors and Anti-Thrombolytic Agents and Uses Thereof
Method of Treating Hereditary Angioedema Using Plasma Kallikrein Binding Antibodies
Methods of Inhibiting Plasma Kallikrein in Edema Patient
Combination Therapy Comprising an Mmp-14 Binding Protein
Ligand Screening and Discovery
Compositions and Methods for Treatment of Diabetic Macular Edema
Multi-Chain Eukaryotic Display Vectors and Uses Thereof
Assays for Determining Levels of Plasma Protease C1 Inhibitor
Methods of Determining Levels of Cleaved and/or Intact Kininogen
Plasma Kallikrein Binding Proteins
Diagnosis and Treatment of Autoimmune Diseases
Assays for Determining Plasma Kallikrein System Biomarkers
Plasma Kallikrein Binding Proteins and Uses Thereof in Treating Hereditary Angioedema
METHODS OF PRODUCING ANTIBODIES TO NEONATAL FC RECEPTOR (FcRn)
Prevention and Reduction of Blood Loss
Libraries of Genetic Packages Comprising Novel Hc CDR1, CDR2, and CDR3 and Novel Lc CDR1, CDR2, and CDR3 Designs
Multi-Chain Eukaryotic Display Vectors and Uses Thereof
Ligand Screening and Discovery
Application:
15/402,724 →
Publication:
US 2017/0240887
Bispecific Antibodies Against Plasma Kallikrein and Factor Xii
Plasma Kallikrein Inhibitors and Uses Thereof for Preventing Hereditary Angioedema Attack
Application:
15/562,671 →
Publication:
US 2018/0298110
Display Library Process
Novel Methods of Constructing Libraries Comprising Displayed and/or Expressed Members of a Diverse Family of Peptides, Polypeptides or Proteins and the Novel Libraries
A Monoclonal Antibody Inhibitor of Factor Xiia
Focused Libraries of Genetic Packages
Fc Receptor Antibodies and Methods of Use Thereof
Libraries of Genetic Packages Comprising Novel Hc CDR3 Designs
Multi-Chain Eukaryotic Display Vectors and Uses Thereof
Diagnosis and Treatment of Autoimmune Diseases
Anti-Plasma Kallikrein Antibodies
Prevention and Reduction of Blood Loss
Methods of Detecting Plasma Kallikrein
Nucleic Acids Encoding Plasma Kallikrein Binding Proteins
Compositions and Methods for Treatment of Diabetic Macular Edema
Nucleic Acids Encoding Anti-Neonatal Fc Receptor (Fcrn) Antibodies
Display Library Process
Focused Libraries of Genetic Packages
Application:
16/789,468 →
Publication:
US 2020/0325469
Libraries of Genetic Packages Comprising Novel Hc CDR1, CDR2, and CDR3 and Novel Lc CDR1, CDR2, and CDR3 Designs
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Release of Security Interest
Aug 22, 2012
From: HEALTHCARE ROYALTY PARTNERS, L.P. F/K/A COWEN HEALTHCARE ROYALTY PARTNERS, L.P.
To: DYAX CORP., A DELAWARE CORPORATION
Reel/Frame 028827/0906 →
Security Agreement
Aug 22, 2012
From: DYAX CORP., A DELAWARE CORPORATION
To: LFRP INVESTORS, L.P., A DELAWARE LIMITED PARTNERSHIP
Reel/Frame 028828/0517 →
Assignment of Security Interest
Oct 20, 2014
From: KGH DOMESTIC III, LP
To: VALEANT HOLDINGS IRELAND
Reel/Frame 034018/0585 →
Release of Security Interest
Oct 28, 2015
From: LFRP INVESTORS, L.P.
To: DYAX CORP.
Reel/Frame 036902/0703 →